Synthesis and evaluation of a brain-targeted catechol derivative as a potential NGF-inducer

International Journal of Pharmaceutics

Volumn 141, Issue 1-2, 1996, Pages 239-250

  Kourounakis, Angeliki ^a   Bodor, Nicholas ^a   Simpkins, James ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Catechol; Central nervous system; Induction; Nerve growth factor

Indexed keywords

CATECHOL DERIVATIVE; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG STABILITY; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030572635     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04642-X     Document Type: Article

References (29)

1. Barde, Y.-A., Trophic factors and neuronal survival. Neuron, 2 (1989) 1525-1534.
2. Bodor, N. and Brewster, M., Problems of delivery of drugs to the brain. Pharm. Ther., 19 (1983) 337-386.
3. Bodor, N. and Farag, H., Improved delivery through biological membranes. 13. Brain specific delivery of dopamine with a dihydropyridine-pyridinium salt type redox delivery system. J. Med. Chem., 26 (1983) 528-534.
4. Brewster, M., Robledo-Luiggi, C., Miyake, A., Pop, E. and Bodor, N., Improved delivery through biological membranes. 44. Brain-enhanced delivery of anti-dementia drugs. In Meyer, E., Simpkins, J. and Yamamoto, J. (Eds), Novel Approaches to the Treatment of Alzheimer's Disease, Plenum, New York, 1989, pp. 173-183.
5. Carswell, S., The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp. Neurol., 124 (1993) 36-42.
6. Carswell, S., Hoffman, E.K., Clopton-Hartpence, K., Wilcox, H.M. and Lewis, M.E., Induction of NGF by isoproterenol. 4-methylcatechol and serum occurs by three distinct mechanisms. Mol. Brain Res., 15 (1992) 145-150.
7. De Bernardi, M.A., Fabrazzo, M. and Mocchetti, I., Transcriptional regulation of nerve growth factor gene. In Costa, E. and Joh, T. (Eds), Neurotransmitter Regulation of Gene Transcription, Thieme, New York. 1991, pp. 37-46.
8. Fisher, W., Wictorin, K., Bjorklund, A., Williams, L.R., Varon, S. and Gage, F.H., Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by NGF. Nature, 329 (1987) 65-68.
9. Follesa, P. and Mocchetti, I., Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol., 43 (1992) 132-138.
10. Furukawa, Y., Furukawa, S., Ikeda, F., Satoyoushi, E. and Hayashi, K., Aliphatic side chain of catecholamine potentiates the stimulatory effect of the catechol part on the synthesis of nerve growth factor. FEBS Lett., 208 (1986a) 258-262.
11. Furukawa, Y., Furukawa, S., Satoyoshi, E. and Hayashi, K., Catecholamines induce an increase in nerve growth factor content in the medium of mouse L-M cells. J. Biol. Chem., 261 (13) (1986b) 6039-6047.
12. Furukawa, Y., Furukawa, S., Satoyoshi, E. and Hayashi, K., Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells. Biochem. Biophys. Res. Commun., 147 (3) (1987) 1048-1054.
13. Furukawa, Y., Tomioka, N., Satoyoshi, E., Hayashi, K. and Furukawa, S., Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells. FEBS Lett., 247 (2) (1989) 463-467.
14. Furukawa, Y., Fukazawa, N., Miyama, Y., Hayashi, K. and Furukawa, S., Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem. Pharmacol., 40 (1991) 2337-2342.
15. Hanaoka, Y., Ohi, T., Furukawa, S., Furukawa, Y., Hayashi, K. and Matwukura, S., The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth-factor synthesis, on experimental diabetic neuropathy in rats. J. Neurol. Sci., 122 (1994) 28-32.
16. Higgins, G.A., Koh, S., Chen, K.S. and Gage, F.H., NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron, 3 (1989) 247-256.
17. Junard, E.O., Montero, C.N. and Hefti, F., Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway. Exp. Neurol., 110 (1990) 25-38.
18. Kaechi, K., Furukawa, Y., Ikegami, R., Nakamura, N., Omae, F., Hashimoto, Y., Hayashi, K. and Furukawa, S., Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system. J. Pharmacol. Exp. Ther., 264 (1993) 321-326.
19. Kourounakis, A., Badawi, M., Bodor, N. and Simpkins, J., Synthesis of two isosters of 4-methylcatechol and evaluation of their NGF-inducing effect. Pharm. Sci., 1 (1995) 407-410.
20. Lapchak, P.A., Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol., 124 (1993) 16-20.
21. Lettre, V.H., Haede, W. and Ruhbaum, E., Zur Darstellung von Derivaten des Nicotinsaureamids. Ann. Chem., 579 (1953) 122-132.
22. Mocchetti, I., Theoretical basis for a pharmacology of nerve growth factor biosynthesis. Ann. Rev. Pharmacol. Toxicol., 32 (1991) 303-28.
23. Olson, L., NGF and the treatment of Alzheimer's diseases. Exp. Neurol., 124 (1993) 5-15.
24. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. Neural Transm., 4 (1992) 79-95.
25. Saporito, M.S., Wilcox, H.M., Hartpence, K.C., Lewis, M.E., Vaught, J.L. and Carswell, S., Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol., 123 (1993) 295-302.
26. Schwartz, J.P., Stimulation of nerve growth factor mRNA content in C6 glioma cells by a β-adrenergic receptor and by cyclic AMP. Glia, 1 (1988) 282-285.
27. Thoenen, H., Zafra, F., Hengerer, B. and Lindholm, D., The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann. N.Y. Acad. Sci., 640 (1991) 86-90.
28. Whittemore, S.R. and Seiger, A., The expression, localization and functional significance of β-nerve growth factor in the central nervous system. Brain Res. Rev., 12 (1987) 439-464.
29. Zincke, T., Ueber Dinitrophenylpyridiniumclorid und Dessen Umwandlungsproducte. Ann. Chem., 33 (1903) 361-382.